Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Statin Use Associates With Risk of Type 2 Diabetes via Epigenetic Patterns at ABCG1

16 Jun 2020

Abstract excerpt

Statin is the medication most widely prescribed to reduce plasma cholesterol levels. Yet, how the medication contributes to diabetes risk and impaired glucose metabolism is not clear. This study aims to examine the epigenetic mechanisms of ABCG1 through which the statin use associates with risk of type 2 diabetes. We determined the association between the statin use, DNA methylation at ABCG1 and type 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol and Lipid Metabolism
Share to Drug Transport and Resistance Mechanisms
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32612641
DOI: 10.3389/fgene.2020.00622

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Statin Use Associates With Risk of Type 2 Diabetes via Epigenetic Patterns at ABCG1PMID 32612641Read ↗

Epigenetic Link Between Statin Therapy and Type 2 Diabetes.Semantic proximity Read ↗

Statin therapy is associated with epigenetic modifications in individuals with Type 2 diabetesSemantic proximity Read ↗

Statins, Type 2 Diabetes, and Body Mass Index: A Univariable and Multivariable Mendelian Randomization Study.Semantic proximity Read ↗

Statin-induced diabetes: incidence, mechanisms, and implicationsSemantic proximity Read ↗

MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapy.Semantic proximity Read ↗

Seventeen years of statin pharmacogenetics: a systematic review.Semantic proximity Read ↗

Adjusting for medication status in genome-wide association studiesSemantic proximity Read ↗

HMGCR genetic variation and risk of new-onset type 2 diabetes in statin users.Semantic proximity Read ↗

Biobank scale pharmacogenomics informs the genetic underpinnings of simvastatin useSemantic proximity Read ↗

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.Semantic proximity Read ↗

Histone deacetylase 9 promoter hypomethylation associated with adipocyte dysfunction is a statin-related metabolic effectSemantic proximity Read ↗

Quantifying the effect of statin use in pre-diabetic phenotypes discovered through association rule mining.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.